Article ID Journal Published Year Pages File Type
8679128 Seminars in Thoracic and Cardiovascular Surgery 2017 19 Pages PDF
Abstract
The National Lung Screening Trial established a survival benefit for lung cancer screening using low-dose computed tomography. In the wake of this trial several international bodies now recommend lung cancer screening. However, three main questions remain unanswered: Who is the optimal population for screening? How often should they be screened? For how long should screening be continued? We examine the results of the available randomized trials to address these questions.
Related Topics
Health Sciences Medicine and Dentistry Cardiology and Cardiovascular Medicine
Authors
, , ,